SARS-CoV-2 spike protein induces salivary gland dysfunction and immune infiltration in C57BL/6 mice
Frontiers in Immunology · 2025
DOI: 10.3389/fimmu.2025.1667597 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Immunology, 2025. Verfasst von Fernanda Aragão Felix und 7 weiteren Autor:innen. Beteiligte Einrichtung: The ADA Forsyth Institute, Somerville, MA, United States. Hauptthemen laut MEDLINE: Spike Glycoprotein, Coronavirus, COVID-19, SARS-CoV-2, Salivary Glands. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDCR NIH HHS, NIAID NIH HHS.
Abstract (Originalsprache)
Salivary gland dysfunction and inflammation are common following SARS-CoV-2 infection. This study aimed to investigate the effects of SARS-CoV-2 spike and envelope proteins on glandular function in healthy C57BL/6 mice through direct intra-glandular injection into the submandibular glands. Local administration of spike protein significantly reduced salivary secretion, while the envelope protein had no measurable impact. Histological analysis revealed the presence of leukocyte foci in two-thirds of spike protein-treated mice, while none were detected in the vehicle- or envelope protein-treated groups. Furthermore, spike protein treatment led to a significant increase in total immune cells and B cells, and an expansion of the CD44 high CD62L low effector/effector memory subsets within CD4 T cells and B cells in the submandibular glands. Notably, serum antinuclear antibodies developed in one-third of spike-treated mice, consistent with the reported salivary gland pathology in COVID-19 patients that resemble autoimmune Sjögren’s disease. Moreover, spike protein treatment increased phospho-STAT3 levels and induced transcriptomic changes indicating impaired acinar compartment, heightened adaptive immune responses, and altered tissue remodeling activity. These findings show that SARS-CoV-2 spike protein alone is sufficient to initiate significant salivary gland pathology in the absence of intact virus or ACE2 interaction, providing evidence for a novel mechanism by which SARS-CoV-2 induces salivary gland dysfunction and pathology with autoimmune features.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The ADA Forsyth Institute, Somerville, MA, United States.
- Department of Oral Surgery, Pathology and Clinical Dentistry, School of Dentistry, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.
- Lab of Oral & Craniofacial Innovation, ADA Science & Research Institute, Gaithersburg, MD, United States.
- Department of Oral and Craniofacial Molecular Biology, Philips Institute for Oral Health Research, Virginia Commonwealth University, Richmond, VA, United States.
Förderung
- NIDCR NIH HHS
- NIAID NIH HHS
Zitieren
APA
Felix, F. A., Jiang, Y., Zhou, J., Li, D., Zhou, V., de Sousa, S. F., Byrd, K. M., & Yu, Q. (2025). SARS-CoV-2 spike protein induces salivary gland dysfunction and immune infiltration in C57BL/6 mice. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2025.1667597
Vancouver
Felix FA, Jiang Y, Zhou J, Li D, Zhou V, de Sousa SF, et al. SARS-CoV-2 spike protein induces salivary gland dysfunction and immune infiltration in C57BL/6 mice. Frontiers in Immunology. 2025. doi:10.3389/fimmu.2025.1667597
BibTeX
@article{Felix2025,
author = {Felix, Fernanda Aragão and Jiang, Yuqiao and Zhou, Jing and Li, Dongfang and Zhou, Victoria and de Sousa, Sílvia Ferreira and Byrd, Kevin Matthew and Yu, Qing},
title = {SARS-CoV-2 spike protein induces salivary gland dysfunction and immune infiltration in C57BL/6 mice},
journal = {Frontiers in Immunology},
year = {2025},
doi = {10.3389/fimmu.2025.1667597}
}
EUVIMED